恒瑞医药二十碳五烯酸乙酯软胶囊获药品注册批准

Group 1 - The core point of the article is that Chengdu Shengdi Pharmaceutical Co., a subsidiary of Heng Rui Medicine, has received approval from the National Medical Products Administration for the launch of Eicosapentaenoic Acid Ethyl Ester Soft Capsules [1] - The approved indication is for the treatment of severe hypertriglyceridemia (≥500 mg/dL) in adult patients, in conjunction with dietary control, to lower triglyceride (TG) levels [1] - The product can also be used in combination with statins for adult patients diagnosed with cardiovascular diseases or diabetes with two or more other cardiovascular disease risk factors, to reduce the risk of cardiovascular events in cases of hypertriglyceridemia (≥150 mg/dL) [1]